• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SCARBOROUGH, INC. ALERE DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SCARBOROUGH, INC. ALERE DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB Back to Search Results
Lot Number 103698
Device Problem False Positive Result (1227)
Patient Problem Pregnancy (3193)
Event Date 04/26/2019
Event Type  Injury  
Manufacturer Narrative
Testing was performed at alere (b)(4) on retained kit lots 103698 and 107842 (exp 21 july 2020) with the following internal serum/plasma control samples: (b)(6) samples.All test results were valid and performed as expected.Additionally, the manufacturing batch records for lots 103698 and 107842 were reviewed.This lot met the required release specifications.A review of the complaints reported as (b)(6) or unconfirmed (b)(6) related to lot numbers 103698 and 107842 showed that the complaint rate is (b)(4).The evidence available does not indicate that the product is performing outside label claims.Alere (b)(4) was unable to determine the exact root cause of the reported issue.The results obtained may possibly be related to the patient sample.The sample may have contained specific substances which may have affected the results.The available evidence suggests that the device lots are performing within labeled claims.
 
Event Description
This report represents the first of three customer reported (b)(6) results with the alere determine hiv-1/2 ag/ab combo test on serum samples from three (3) patients.(b)(6) antibody (ab) results were reported on a pregnant female patient before delivery.The test was repeated on two (2) different lots (lot #: 103698; 107842), three (3) times on each lot.Confirmatory testing on the pregnant patient was performed on a 4th generation hiv chemiluminescence test and reported as (b)(6).Rna viral load testing was performed and reported as (b)(6).Prior to confirmation of test results, a cesarean section was performed based on the (b)(6) rapid hiv test generated by the alere determine hiv-1/2 ag/ab combo.The patient received (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE DETERMINE HIV-1/2 AG/AB COMBO
Type of Device
IVD FOR HIV 1/2 AG/AB
Manufacturer (Section D)
ALERE SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
erin rowley
10 southgate road
scarborough, ME 04074
2077305858
MDR Report Key8645350
MDR Text Key146227761
Report Number1221359-2019-00027
Device Sequence Number1
Product Code MZF
UDI-Device Identifier10811877010293
UDI-Public011081187701029310103698
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP120037-0
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/20/2020
Device Lot Number103698
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/02/2019
Initial Date FDA Received05/28/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/29/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age22 YR
Patient Weight109
-
-